Ausgabe 2/2019
Inhalt (26 Artikel)
Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
Christoph J. Rageth, Elizabeth A. M. O’Flynn, Katja Pinker, Rahel A. Kubik-Huch, Alexander Mundinger, Thomas Decker, Christoph Tausch, Florian Dammann, Pascal A. Baltzer, Eva Maria Fallenberg, Maria P. Foschini, Sophie Dellas, Michael Knauer, Caroline Malhaire, Martin Sonnenschein, Andreas Boos, Elisabeth Morris, Zsuzsanna Varga
Identifying adherence barriers to oral endocrine therapy among breast cancer survivors
Rutugandha Paranjpe, Grace John, Meghana Trivedi, Susan Abughosh
Leveraging the variable natural history of ductal carcinoma in situ (DCIS) to select optimal therapy
Kristin E. Rojas, Thais A. Fortes, Patrick I. Borgen
Clinical findings and outcomes of MRI staging of breast cancer in a diverse population
Akshara Raghavendra, Julie Wecsler, Lingyun Ji, Pulin Sheth, Charite Ricker, Terry Church, Richard Sposto, Julie Lang, Stephen Sener, Linda Larsen, Debu Tripathy
Peer support interventions for breast cancer patients: a systematic review
Jieman Hu, Xue Wang, Shaoning Guo, Fangfang Chen, Yuan-yu Wu, Fu-jian Ji, Xuedong Fang
An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer
Anagha Gogate, Jason S. Rotter, Justin G. Trogdon, Ke Meng, Christopher D. Baggett, Katherine E. Reeder-Hayes, Stephanie B. Wheeler
The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis
Pierre O’Brien, Kara Matheson, Alwin Jeyakumar, Kim Anderson, Tallal Younis
Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours
Sue Zann Lim, Cedric Chuan Young Ng, Vikneswari Rajasegaran, Peiyong Guan, Sathiyamoorthy Selvarajan, Aye Aye Thike, Nur Diyana Binte Md Nasir, Valerie Cui Yun Koh, Benita Kiat Tee Tan, Kong Wee Ong, Bin Tean Teh, Puay Hoon Tan
KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients
Xi-Mei Wang, Zhen Zhang, Li-Hui Pan, Xu-Chen Cao, Chunhua Xiao
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
Chitra Joseph, Maariya Arshad, Sasagu Kurozomi, Maryam Althobiti, Islam M. Miligy, Sara Al-izzi, Michael S. Toss, Fang Qin Goh, Simon J. Johnston, Stewart G. Martin, Ian O. Ellis, Nigel P. Mongan, Andrew R. Green, Emad A. Rakha
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies
Berry Button, Sarah Croessmann, David Chu, D. Marc Rosen, Daniel J. Zabransky, W. Brian Dalton, Karen Cravero, Kelly Kyker-Snowman, Ian Waters, Swathi Karthikeyan, Eric S. Christenson, Josh Donaldson, Tasha Hunter, Lauren Dennison, Cody Ramin, Betty May, Richard Roden, Dana Petry, Deborah K. Armstrong, Kala Visvanathan, Ben Ho Park
Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence
Matthew A. Lyes, Sturgis Payne, Paul Ferrell, Salvatore V. Pizzo, Scott T. Hollenbeck, Robin E. Bachelder
Combination of different types of elastography in downgrading ultrasound Breast Imaging-Reporting and Data System category 4a breast lesions
Xueyi Zheng, Yini Huang, Yun Wang, Yubo Liu, Fei Li, Jing Han, Jianwei Wang, Longhui Cao, Jianhua Zhou
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial
O. Nanni, D. Amadori, A. De Censi, A. Rocca, A. Freschi, A. Bologna, L. Gianni, F. Rosetti, L. Amaducci, L. Cavanna, F. Foca, S. Sarti, P. Serra, L. Valmorri, P. Bruzzi, D. Corradengo, A. Gennari, Laura Scaltriti, Gianni Michele Turolla, Claudio Dazzi, Laura Cortesi, Petros Giovanis, Silvana Saracchini, Mariangela Ciccarese, Francesco Carrozza
Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer
Dilan A. Patel, Jing Xi, Jingqin Luo, Bilal Hassan, Shana Thomas, Cynthia X. Ma, Jian L. Campian
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer
Marius Wunderle, Jutta Pretscher, Sara Y. Brucker, Bernhard Volz, Arndt Hartmann, Cornelia Fiessler, Alexander Hein, Lothar Häberle, Sebastian M. Jud, Michael P. Lux, Wolfgang Janni, Christian R. Loehberg, Andreas D. Hartkopf, Christina B. Walter, Gerold Baake, Alexander Fridman, Wolfram Malter, Rachel Wuerstlein, Nadia Harbeck, Oliver Hoffmann, Sherko Kümmel, Bernhard Martin, Christoph Thomssen, Heiko Graf, Christopher Wolf, Christian M. Bayer, Carolin C. Hack, Katrin Almstedt, Paul Gass, Felix Heindl, Tobias F. Brodkorb, Naiba Nabieva, Christoph Lindner, Hans-Christian Kolberg, Petra Krabisch, Michael Weigel, Dieter Steinfeld-Birg, Andreas Kohls, Cosima Brucker, Volker Schulz, Gunnar Fischer, Volker Pelzer, Diethelm Wallwiener, Brigitte Rack, Tanja Fehm, Achim Rody, Nicolai Maass, Matthias W. Beckmann, Peter A. Fasching, Claudia Rauh
Yield of surveillance magnetic resonance imaging after bilateral mastectomy and reconstruction: a retrospective cohort study
Orit Golan, Yoav Amitai, Yoav Barnea, Tehillah S. Menes
A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families
Talia Donenberg, Sophia George, Jameel Ali, Gabriela Bravo, Karen Hernandez, Navin Sookar, Kimlin Tam Ashing, Steven A. Narod, Mohammad R. Akbari, Judith Hurley
Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands
Carmen van Dooijeweert, Paul J. van Diest, Stefan M. Willems, Chantal C. H. J. Kuijpers, Lucy I. H. Overbeek, Ivette A. G. Deckers
Diagnostic pathways and management in women with pregnancy-associated breast cancer (PABC): no evidence of treatment delays following a first healthcare contact
Anna L. V. Johansson, Caroline E. Weibull, Irma Fredriksson, Mats Lambe
Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011
Judith Malmgren, Marc Hurlbert, Mary Atwood, Henry G. Kaplan
Prevalence of breast cancer-related risk factors in underweight premenopausal women: the Korea National Health and Nutrition Examination Survey IV–VI
Joo Heung Kim, Kwang Hyun Yoon, Ho Hur, Seho Park, Jee Ye Kim, Hyung Seok Park, Seung II Kim, Young Up Cho, Byeong-Woo Park
The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women’s characteristics: is it the same?
Isabelle Théberge, Nathalie Vandal, Marie-Hélène Guertin, Linda Perron
Patient-centered simulations to assess the usefulness of the 70-gene signature for adjuvant chemotherapy administration in early-stage breast cancer
Emmanuel Caruana, Yohann Foucher, Philippe Tessier, Jean-Sébastien Frenel, Jean-Marc Classe, Etienne Dantan
Alternative transcript imbalance underlying breast cancer susceptibility in a family carrying PALB2 c.3201+5G>T
Laura Duran-Lozano, Gemma Montalban, Sandra Bonache, Alejandro Moles-Fernández, Anna Tenés, Marta Castroviejo-Bermejo, Estela Carrasco, Adrià López-Fernández, Sara Torres-Esquius, Neus Gadea, Neda Stjepanovic, Judith Balmaña, Sara Gutiérrez-Enríquez, Orland Diez
Ectopic breast tissue and cancer
Alessandro Sindoni, Maria Gioffré-Florio, Fausto Famá